Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Illumina Inc. A complete text table follows the diagram.
Consumables generate nearly three quarters of revenue, turning every installed sequencing system into an ongoing demand engine
Swipe to explore
Every displayed flow is an exact reported quarterly revenue amount. The visual reorganizes the filing's two-dimensional revenue table without modeled allocation.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Illumina revenue | 1 | $1.1B | Genomics and emerging multiomics |
| DNA sequencing | 2 | $995M | 91% of company revenue |
| Microarray analysis | 2 | $96M | Genotyping and array workflows |
| Sequencing consumables | 3 | $726M | Reagents and flow cells |
| Sequencing instruments | 3 | $118M | Installed-base expansion |
| Sequencing services | 3 | $151M | Service contracts, testing and licensing |
| Microarray consumables | 3 | $71M | Recurring array usage |
| Microarray instruments | 3 | $2M | New array systems |
| Microarray services | 3 | $23M | Genotyping and related services |
| From | To | Value |
|---|---|---|
| Illumina revenue | DNA sequencing | $995M |
| Illumina revenue | Microarray analysis | $96M |
| DNA sequencing | Sequencing consumables | $726M |
| DNA sequencing | Sequencing instruments | $118M |
| DNA sequencing | Sequencing services | $151M |
| Microarray analysis | Microarray consumables | $71M |
| Microarray analysis | Microarray instruments | $2M |
| Microarray analysis | Microarray services | $23M |